TIDM0Y4Q
RNS Number : 0573I
BlackRock Group
30 March 2020
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing BlackRock, Inc.
(Note 1)
Company dealt in Willis Towers Watson plc
========================
Class of relevant security US$0.000304635 ordinary
to which the dealings shares
being disclosed relate
(Note 2)
========================
Date of dealing 27 March 2020
========================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
=========== ======= =========== ======
(1) Relevant securities 11,912,355 (9.25%) 32 (0.00%)
==================== ===================
(2) Derivatives (other
than options) 108,436 (0.08%) 5,636 (0.00%)
==================== ===================
(3) Options and agreements
to purchase/sell 0 (0.00%) 79,300 (0.06%)
==================== ===================
Total 12,020,791 (9.33%) 84,968 (0.06%)
==================== ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities
=================== =====================
(2) Derivatives (other
than options)
=================== =====================
(3) Options and agreements
to purchase/sell
=================== =====================
Total
=================== =====================
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
Purchase 1,100 USD 158.4164
====================================== ====================
Purchase 49 USD 162.7550
====================================== ====================
Purchase 224 USD 166.1584
====================================== ====================
Purchase 3,642 USD 167.2100
====================================== ====================
Purchase 85 USD 170.5000
====================================== ====================
Sale 10 USD 165.7170
====================================== ====================
Sale 39,120 USD 166.8512
====================================== ====================
Sale 1,556 USD 167.2100
====================================== ====================
Please note: there was also a Transfer In of 8,537 Shares
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
CFD Increasing Long 1,574 USD 159.3086
===================== ================== ============
CFD Reducing Short 6 USD 167.2100
===================== ================== ============
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Stock on Loan 9,400 N/A
============== ====================
Return of Stock 27,109 N/A
on Loan
============== ====================
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any
other person relating to the voting rights of any relevant
securities under any option referred to on this
form or relating to the voting rights or future acquisition or
disposal of any relevant securities to
which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure 30 March 2020
Contact name Jana Blumenstein
================
Telephone number +44 20 7743 3650
================
If a connected EFM, name
of offeree/offeror with
which connected
================
If a connected EFM, state
nature of connection (Note
10)
================
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form
8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product Written, Number of relevant Exercise Type, e.g. Expiry
name, or purchased securities price American, date
e.g. call to which the (Note European
option option or derivative 2) etc.
relates
Call Option Written 33,200 USD 208.0000 European 02/04/2020
============== ====================== ============ ========== ==========
Call Option Written 900 USD 220.0000 American 17/04/2020
============== ====================== ============ ========== ==========
Call Option Written 19,700 USD 170.0000 American 17/04/2020
============== ====================== ============ ========== ==========
Call Option Written 25,500 USD 215.0000 European 17/04/2020
============== ====================== ============ ========== ==========
Notes
1. Where there are open option positions or open derivative
positions (except for CFDs), full details should be given. Full
details of any existing agreements to purchase or to sell must also
be
given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosur e requirements, see Rule 8 of the
Rules. If in doubt, consult the Panel.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEJMMMTMTJJBLM
(END) Dow Jones Newswires
March 30, 2020 10:20 ET (14:20 GMT)
Willis Towers Watson (LSE:0Y4Q)
Historical Stock Chart
From Apr 2024 to May 2024
Willis Towers Watson (LSE:0Y4Q)
Historical Stock Chart
From May 2023 to May 2024